PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer.

Autor: Khan, Sajid1,2 (AUTHOR) khans10@uthscsa.edu, Cao, Lin1 (AUTHOR), Wiegand, Janet3 (AUTHOR), Zhang, Peiyi4 (AUTHOR), Zajac-Kaye, Maria5 (AUTHOR), Kaye, Frederic J.6 (AUTHOR), Zheng, Guangrong4 (AUTHOR), Zhou, Daohong1,2 (AUTHOR)
Zdroj: Cells (2073-4409). Mar2024, Vol. 13 Issue 6, p528. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje